Printer Friendly

Printed from http://www.researchandmarkets.com/reports/2113059

OTC Pharmaceuticals in Switzerland

Description:
Introduction

OTC Pharmaceuticals in Switzerland industry profile provides top-line qualitative and quantitative summary information including: market share, market size (value and volume 2008-12, and forecast to 2017). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market. Essential resource for top-line data and analysis covering the Switzerland otc pharmaceuticals market. Includes market size and segmentation data, textual and graphical analysis of market growth trends, leading companies and macroeconomic information.

Highlights

- The OTC pharmaceuticals market consists of the retail sale of traditional medicines, cough and cold preparations (tablets, mixtures, lozenges, topical remedies, inhalers), vitamins and minerals (multi-vitamins, single minerals, single vitamins, tonics, cod liver oil), indigestion preparations (tablets, powders, mixtures), analgesics (Paracetamol, Ibuprofen, Aspirinand other analgesics), and medicated skin products (anti-bacteria’s, acne treatments, anti-fungal, disinfectants and other), topical OTC medicines (anesthetic products, anti-itch products, antibiotic creams/gels), plasters & bandages (adhesive bandages/plasters, first aid tape, gauze pads/rolled gauze, liquid bandages and other tape or bandage), first aid kits and other (anti-smoking aids, rectal medications, eye/ear drops, sleeping aids, and motion sickness). The market is valued according to retail selling price (RSP) and includes any applicable taxes. Any currency conversions used in the creation of this report have been calculated using constant 2012 annual average exchange rates.

- The Swiss OTC pharmaceuticals market had total revenues of $1,298.7m in 2012, representing a compound annual growth rate (CAGR) of 1.7% between 2008 and 2012.

- The cough and cold preparations segment was the market's most lucrative in 2012, with total revenues of $305.2m, equivalent to 23.5% of the market's overall value.

- The performance of the market is forecast to follow the similar pattern with an anticipated CARC of 1.6% for the five-year period 2012 - 2017, which is expected to drive the market to a value of $1,402.6m by the end of 2017.

Features

Save time carrying out entry-level research by identifying the size, growth, major segments, and leading players in the otc pharmaceuticals market in Switzerland

Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the otc pharmaceuticals market in Switzerland

Leading company profiles reveal details of key otc pharmaceuticals market players’ global operations and financial performance

Add weight to presentations and pitches by understanding the future growth prospects of the Switzerland otc pharmaceuticals market with five year forecasts by both value and volume

Macroeconomic indicators provide insight into general trends within the Switzerland economy

Key Questions Answered

What was the size of the Switzerland otc pharmaceuticals market by value in 2012?

What will be the size of the Switzerland otc pharmaceuticals market in 2017?

What factors are affecting the strength of competition in the Switzerland otc pharmaceuticals market?

How has the market performed over the last five years?

Who are the top competitiors in Switzerland's otc pharmaceuticals market?
 
Contents:
Executive Summary
Market value
Market value forecast
Category segmentation
Market share
Market rivalry
Market Overview
Market definition
Market analysis
Market Data
Market value
Market Segmentation
Category segmentation
Market share
Market distribution
Market Outlook
Market value forecast
Five Forces Analysis
Summary
Buyer power
Supplier power
New entrants
Threat of substitutes
Degree of rivalry
Leading Companies
Bayer AG
GlaxoSmithKline Plc
Johnson & Johnson
Novartis AG
Macroeconomic Indicators
Country Data
Appendix
Methodology
Industry associations
Related MarketLine research

LIST OF TABLES
Table 1: Switzerland OTC pharmaceuticals market value: $ million, 2008–12
Table 2: Switzerland OTC pharmaceuticals market category segmentation: $ million, 2012
Table 3: Switzerland OTC pharmaceuticals market share: % share, by value, 2012
Table 4: Switzerland OTC pharmaceuticals market distribution: % share, by value, 2012
Table 5: Switzerland OTC pharmaceuticals market value forecast: $ million, 2012–17
Table 6: Bayer AG: key facts
Table 7: Bayer AG: key financials ($)
Table 8: Bayer AG: key financials (€)
Table 9: Bayer AG: key financial ratios
Table 10: GlaxoSmithKline Plc: key facts
Table 11: GlaxoSmithKline Plc: key financials ($)
Table 12: GlaxoSmithKline Plc: key financials (£)
Table 13: GlaxoSmithKline Plc: key financial ratios
Table 14: Johnson & Johnson: key facts
Table 15: Johnson & Johnson: key financials ($)
Table 16: Johnson & Johnson: key financial ratios
Table 17: Novartis AG: key facts
Table 18: Novartis AG: key financials ($)
Table 19: Novartis AG: key financial ratios
Table 20: Switzerland size of population (million), 2008–12
Table 21: Switzerland gdp (constant 2000 prices, $ billion), 2008–12
Table 22: Switzerland gdp (current prices, $ billion), 2008–12
Table 23: Switzerland inflation, 2008–12
Table 24: Switzerland consumer price index (absolute), 2008–12
Table 25: Switzerland exchange rate, 2008–12

LIST OF FIGURES
Figure 1: Switzerland OTC pharmaceuticals market value: $ million, 2008–12
Figure 2: Switzerland OTC pharmaceuticals market category segmentation: % share, by value, 2012
Figure 3: Switzerland OTC pharmaceuticals market share: % share, by value, 2012
Figure 4: Switzerland OTC pharmaceuticals market distribution: % share, by value, 2012
Figure 5: Switzerland OTC pharmaceuticals market value forecast: $ million, 2012–17
Figure 6: Forces driving competition in the OTC pharmaceuticals market in Switzerland, 2012
Figure 7: Drivers of buyer power in the OTC pharmaceuticals market in Switzerland, 2012
Figure 8: Drivers of supplier power in the OTC pharmaceuticals market in Switzerland, 2012
Figure 9: Factors influencing the likelihood of new entrants in the OTC pharmaceuticals market in Switzerland, 2012
Figure 10: Factors influencing the threat of substitutes in the OTC pharmaceuticals market in Switzerland, 2012
Figure 11: Drivers of degree of rivalry in the OTC pharmaceuticals market in Switzerland, 2012
Figure 12: Bayer AG: revenues & profitability
Figure 13: Bayer AG: assets & liabilities
Figure 14: GlaxoSmithKline Plc: revenues & profitability
Figure 15: GlaxoSmithKline Plc: assets & liabilities
Figure 16: Johnson & Johnson: revenues & profitability
Figure 17: Johnson & Johnson: assets & liabilities
Figure 18: Novartis AG: revenues & profitability
Figure 19: Novartis AG: assets & liabilities
 
Companies Mentioned
Bayer AG, GlaxoSmithKline Plc, Johnson & Johnson and Novartis AG
 
Ordering:
Order Online - visit http://www.researchandmarkets.com/reports/2113059

Order by Fax - using the order form below

Order By Post - print the order form below and send to

Research and Markets,
Guinness Centre,
Taylors Lane,
Dublin 8,
Ireland.

 
Page 1 of 2
Printed Oct 25th 2014
4:05:49 AM

Fax order form

To place a fax order simply print this form, fill in and fax the completed form to the number below. If you have any questions please email help@researchandmarkets.net

Order information

Please verify that the product information is correct and select the format you require.

Product name

OTC Pharmaceuticals in Switzerland

Web Address

http://www.researchandmarkets.com/reports/2113059

Office Code

SCOI7T

 

Report Formats

Please enter the quantity of the report format you require.

Format Quantity Price
Electronic (PDF) - Single User USD 350
Electronic (PDF) - Enterprisewide USD 875

Contact information

Please enter all the information below in block capitals.

Title:
Mr Mrs Dr Miss Ms Prof
First Name:
Last Name:
Email Address:
Job Title:
Organisation:
Address:
City:
Postal / Zip Code:
Country:
Phone Number:
Fax Number:

Please fax this form to:
(646) 607-1907 or (646) 964-6609 (from USA)
+353-1-481-1716 or +353-1-653-1571 (from Rest of World)

Page 2 of 2
Printed Oct 25th 2014
4:05:49 AM

Payment information

Please indicate the payment method you would like to use by selecting the appropriate box.

Pay by Credit Card:

American Express

Diners Club

Master Card

Visa

Cardholder's Name:
Cardholder's Signature:
Expiry Date:
/
Card Number:
CVV Security Code:
Issue date:
/ (Diners Club only)
 
Pay by Check:

Please post the check, accompanied by this form, to:

Research and Markets,
Guinness Centre,
Taylors Lane,
Dublin 8,
Ireland.

 
Pay by Wire Transfer:

Please transfer funds to:

Account Number:
83313083
Sort Code:
98-53-30
Swift Code:
ULSBIE2D
IBAN Number:
IE78ULSB98533083313083
Bank Address:
Ulster Bank,
27-35 Main Street
Blackrock,
Co. Dublin
Ireland.
 

If you have a Marketing Code please enter it below:

Marketing Code:

Please note that by ordering from Research and Markets you are agreeing to our Terms and Conditions at http://www.researchandmarkets.com/info/terms.asp

Please fax this form to:
(646) 607-1907 or (646) 964-6609 (from USA)
+353-1-481-1716 or +353-1-653-1571 (from Rest of World)